Concepedia

Marcus P. Kelly

MP

19

Publications

1.1K

Citations

17

H-Index

2005

Active since

Affiliations

Regeneron (United States)(Current)

Austin Hospital

Ludwig Cancer Research

National Cancer Institute

Ludwig Cancer Research

Marcus P. Kelly is an author at Regeneron (United States) specializing in medicine, radiation oncology, and immunology.

ORCID

Top concepts

Publications per year

2005–2022

19

Publications

19

Bispecific Antibodies and Antibody–Drug Conjugates (ADCs) Bridging HER2 and Prolactin Receptor Improve Efficacy of HER2 ADCs

Julian Andreev, Nithya Thambi, Andrés E. Perez Bay et al. · Molecular Cancer Therapeutics · 2017 · 161 citations

A Mucin 16 bispecific T cell–engaging antibody for the treatment of ovarian cancer

Alison Crawford, Lauric Haber, Marcus P. Kelly et al. · Science Translational Medicine · 2019 · 137 citations · Full text

Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase

Marcus P. Kelly, Achim A. Jungbluth, B-W Wu et al. · British Journal of Cancer · 2011 · 122 citations · Full text

Antibody-Targeted NY-ESO-1 to Mannose Receptor or DEC-205 In Vitro Elicits Dual Human CD8+ and CD4+ T Cell Responses with Broad Antigen Specificity

Takemasa Tsuji, Junko Matsuzaki, Marcus P. Kelly et al. · The Journal of Immunology · 2010 · 116 citations · Full text

, , +17

Generation of T-cell-redirecting bispecific antibodies with differentiated profiles of cytokine release and biodistribution by CD3 affinity tuning

Lauric Haber, Kara Olson, Marcus P. Kelly et al. · Scientific Reports · 2021 · 93 citations · Full text

Rows per page

1–5 of 19